This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Acorda Therapeutics Inc (ACOR)

NASDAQ: Health Care

Company Balance Sheet
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Assets
Cash and Equivalents 153.20M 182.17M 48.04M 41.88M
Receivables 31.47M 32.21M 30.78M 26.33M
Inventories 36.48M 26.84M 26.17M 20.96M
Other Current Assets 7.96M 7.32M 8.46M 16.48M
Total Current Assets 451.32M 409.14M 367.33M 333.06M
Property, Plant & Equipment, Gross 65.83M 59.82M 25.08M 25.84M
Accumulated Depreciation & Depletion 25.63M 13.73M 8.55M 9.13M
Property, Plant & Equipment, Net 40.20M 46.09M 16.52M 16.71M
Intangibles 430.86M 432.82M 17.46M 9.32M
Other Non-Current Assets 8.20M 9.68M 97.83M 104.61M
Total Non-Current Assets 665.03M 671.54M 239.79M 232.27M
Liabilities & Shareholder Equity
Total Assets 1.12B 1.08B 607.13M 565.33M
Accounts Payable 17.07M 30.99M 15.92M 30.54M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 90.59M 114.38M 96.64M 98.87M
Long Term Debt 296.58M 289.88M 3.23M 4.57M
Deferred Income Taxes 12.15M 23.89M 0.00 0.00
Other Non-Current Liabilities 114.00M 112.27M 66.90M 75.97M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 422.73M 426.04M 70.13M 80.54M
Total Liabilities 513.32M 540.42M 166.77M 179.41M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 603.02M 540.25M 440.35M 385.92M
Common Par 43.00K 42.00K 41.00K 40.00K
Additional Paid In Capital 812.78M 761.03M 678.69M 640.67M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -209.35M -220.41M -238.08M -254.52M
Treasury Stock -329.00K -329.00K -329.00K -329.00K
Other Equity Adjustments -119.00K -74.00K 37.00K 62.00K
Total Capitalization 899.60M 830.14M 443.58M 390.49M
Total Equity 603.02M 540.25M 440.35M 385.92M
Total Liabilities & Stock Equity 1.12B 1.08B 607.13M 565.33M
Total Common Shares Outstanding 42.99M 41.87M 40.88M 39.79M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 12.42K 12.42K 12.42K 12.42K
Basic Weighted Shares Outstanding 42.23M 41.15M 40.21M 39.46M
Diluted Weighted Shares Outstanding 43.62M 42.54M 41.68M 40.33M
Number of Employees 535 489 421 378
Number of Part-Time Employees 0 0 0 0
ACOR News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

ACOR Acorda Therapeutics Inc

Chart of ACOR

Analysts Ratings for ACOR

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ACOR ANALYST REPORT

ACOR Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs